Jason Hoitt Net Worth & Insider Trades

Jason Hoitt - Chief Commercial Officer, Provention Bio, Inc

As of April 27, 2023

What is Jason Hoitt's Net Worth?

The current estimated net worth of Provention Bio, Inc's Chief Commercial Officer, Jason Hoitt, is estimated to be about $664.59K . Jason Hoitt owns about 0 unit of Provention Bio, Inc common stock. In the last 3 years at Provention Bio, Inc, Jason Hoitt has sold an estimated value of $45.01K worth.

What is Jason Hoitt's Past Insider Trading?

Jason Hoitt's largest purchase order was 4,500 units , worth over $24.43K on March 20, 2020. Jason Hoitt's largest sale order was 4,500 units , worth over $45.01K on February 14, 2023. In total, Jason Hoitt has made about 9 transactions over 3 years of their time at Provention Bio, Inc. Jason Hoitt usually trades in January, with the busiest year in 2023 and 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Jason Hoitt's' Mailing Address?

  • Mailing address is C/o Dova Pharmaceuticals, Inc. 240 Leigh Farm Road, Suite 245 Durham NC 27707 NC

What are Provention Bio, Inc's Past Insider Trades?

Provention Bio, Inc's most recent insider trade came on April 18, 2023 by Sessa Capital Master Lp, Sessa Capital GP Llc, Sessa Capital Im Lp, Sessa Capital Im GP Llc and John Petry who sold 2,190,549 units worth $53.27M . In the last 5 years, insiders at Provention Bio, Inc have sold an estimated value of $85.68M and bought an estimated value of $59.76M worth of shares. Insider trading is most common in December, with the busiest year in 2023. The most active traders at the company are Francisco Leon, Chief Scientific Officer,  Anthony Digiandomenico, Director,  and Ashleigh Palmer, Director and CEO .

Provention Bio, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...